What clinical trials has felodipine been studied in?
Felodipine has been studied in multiple areas where calcium-channel blockers are used, most commonly hypertension and other cardiovascular conditions. Trial designs typically evaluate blood-pressure reduction, safety/tolerability, and—depending on the study—effects on heart-related outcomes, kidney function, or cardiovascular risk markers.
What conditions are felodipine trials usually targeting?
Most felodipine clinical research focuses on:
- Hypertension (alone or compared with other blood-pressure medicines)
- Stable cardiovascular disease and related cardiovascular endpoints
- Studies involving kidney disease or kidney-related blood-pressure management (commonly measured via renal function and albuminuria in some protocols)
- Dose, formulation, and long-term safety trials that test how well patients maintain blood-pressure control over time
Do any felodipine trials compare it against other blood pressure drugs?
Common trial structures for felodipine include head-to-head comparisons with other antihypertensives (such as ACE inhibitors, ARBs, diuretics, or other calcium-channel blockers), or add-on studies where felodipine is added when target blood pressure is not reached. These trials usually look at average blood-pressure change from baseline, time to reach control, and rates of adverse events.
What outcomes do researchers measure in felodipine trials?
Across felodipine studies, typical endpoints include:
- Systolic and diastolic blood-pressure change (clinic or ambulatory)
- Proportion of participants reaching target blood pressure
- Safety outcomes such as peripheral edema, headache, dizziness, flushing, and hypotension
- Long-term outcomes when trials are large enough, such as cardiovascular events (varies by study)
Are there specific felodipine side effects people ask about in trials?
The side effects most often tracked in calcium-channel blocker studies include peripheral edema (swelling, often in the lower legs), headache, flushing, dizziness, and constipation. Trial reporting usually ties these to dose and to whether felodipine is used alone or combined with other antihypertensive classes.
Where can I find an exact felodipine trial (NCT number, results, inclusion criteria)?
To pull a specific “clinical trial on felodipine” with details (trial phase, country, eligibility criteria, endpoints, and posted results), I need one more detail from you:
- Are you looking for hypertension trials, cardiovascular outcomes trials, or something else?
- Do you want trials that are completed and have results, or ongoing studies?
- Any age group (adults vs elderly), or a specific country/region?
If you share the condition or goal, I can help narrow down the most relevant trial listings and summarize what those studies tested.
Is there a patent/exclusivity angle for felodipine trials?
Felodipine is an older drug, so the patent situation may differ from newer therapies. If you want to check exclusivity or patent coverage for a particular felodipine brand/generic in a specific country, DrugPatentWatch.com can be a useful starting point: DrugPatentWatch.com.
Tell me which felodipine trial you mean
If you paste any of the following, I can summarize the study more precisely:
- a ClinicalTrials.gov link
- an NCT number
- the disease/indication (e.g., hypertension, angina, kidney-related BP control)
- trial phase (if known)
Sources: none cited (the prompt didn’t provide specific trial identifiers or study sources).